Literature DB >> 4007041

Comparison of atenolol 50 mg and 100 mg as initial treatment in uncomplicated mild to moderate hypertension.

E van der Veur, B S ten Berge, A J Donker, J F May, F H Schuurman, H Wesseling.   

Abstract

After screening a local population in the northern part of The Netherlands for hypertension, 59 patients with a diastolic pressure (DP) between 95 and 130 mmHg were randomized and treated either with 50 mg atenolol (n = 29) or 100 mg atenolol (n = 30) for 1 month. There was no significant difference between the two treatments, neither in the fall in systolic and diastolic pressures nor in the number of complaints reported. It is concluded that in the initial treatment of uncomplicated mild to moderate hypertension, 100 mg atenolol has no advantage over a 50 mg dose.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4007041     DOI: 10.1007/bf00543336

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Dose response and frequency of administration of atenolol in essential hypertension--once daily treatment with beta-blockade.

Authors:  A J Marshall; D W Barritt; J D Harry
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

2.  Atenolol in hypertension: a double-blind comparison of the response to three different doses.

Authors:  F J Zacharias; P J Hayes; J M Cruickshank
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

3.  A dose-response study of atenolol in mild to moderate hypertension in general practice.

Authors:  N K Gostick; S R Mayhew; R Million; D Sagar; S R Suxena; D F Ingram; N P Barmer
Journal:  Curr Med Res Opin       Date:  1977       Impact factor: 2.580

4.  Relationship between blood level of atenolol and pharmacologic effect.

Authors:  A Amery; J F De Plaen; P Lijnen; J McAinsh; T Reybrouck
Journal:  Clin Pharmacol Ther       Date:  1977-06       Impact factor: 6.875

5.  Comparison of hydrochlorothiazide and atenolol as initial treatment in uncomplicated hypertension.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Atenolol once-daily in hypertension.

Authors:  T A Jeffers; J Webster; J C Petrie; N P Barker
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

7.  Atenolol and metoprolol once daily in hypertension.

Authors:  A K Scott; J W Rigby; J Webster; G M Hawksworth; J C Petrie; H G Lovell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-22
  7 in total
  3 in total

Review 1.  Allopathy--the therapeutic legacy.

Authors:  G D Johnston
Journal:  Ir J Med Sci       Date:  1989-01       Impact factor: 1.568

Review 2.  Selecting appropriate antihypertensive drug dosages.

Authors:  G D Johnston
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 3.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.